Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Depreciation and Depletion (2023 - 2025)

Mangoceuticals (MGRX) has disclosed Depreciation and Depletion for 3 consecutive years, with $255.0 as the latest value for Q4 2025.

  • Quarterly Depreciation and Depletion changed 0.0% to $255.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1012.0 through Dec 2025, down 89.81% year-over-year, with the annual reading at $1012.0 for FY2025, 89.81% down from the prior year.
  • Depreciation and Depletion hit $255.0 in Q4 2025 for Mangoceuticals, roughly flat from $255.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $6292.0 in Q3 2023 to a low of $250.0 in Q1 2025.
  • Historically, Depreciation and Depletion has averaged $2986.4 across 3 years, with a median of $1730.0 in 2024.
  • Biggest YoY gain for Depreciation and Depletion was 2.33% in 2024; the steepest drop was 95.99% in 2024.
  • Year by year, Depreciation and Depletion stood at $6291.0 in 2023, then crashed by 95.95% to $255.0 in 2024, then changed by 0.0% to $255.0 in 2025.
  • Business Quant data shows Depreciation and Depletion for MGRX at $255.0 in Q4 2025, $255.0 in Q3 2025, and $252.0 in Q2 2025.